Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma

NCT04151667 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Daratumumab Injection
DRUG: Dexamethasone Oral
DRUG: Lenalidomide Pill
DRUG: Bortezomib Injection

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]